India is slowly turning into a hotbed for cancer research, and one of the propelling reasons for this is the increasing incidence of cancer in the country. As it stands, India starts 10th globally in terms of pharmaceutical research. And due to extremely stringent laws existing earlier, the sphere of clinical trials was also on a downturn; this has changed with better, pragmatic laws being in place. With almost 1.5 million people being diagnosed with the disease every year in the country, India needs to focus more of its energies and resources on cancer research for therapy as well as faster diagnosis.

This issue also looks at the story of Grail Inc., a US-based company that wants to figure out the holy grail of cancer detection: a blood test that will detect cancer even before it shows any kind of symptoms. In the NGO section, we have a true story of a survivor, whose work withstands even death. Rahul Yadav founded the UNESCO-award winning Yoddhas when he was fighting cancer; his wife carries on his legacy even after his death. And we also have our exciting back-of-the-book section, with snazzy automobiles, nifty gadgets, movies, fashion and books. Let this issue set you on a path of exploration and discovery.

Dr Ulhas Ganu
Editor-in-Chief
[email protected]